Follow

A CRISPR-based strategy to promote endogenous fetal hemoglobin re-expression to treat sickle cell disease: my latest Nature Medicine column.

nature.com/articles/d41591-023

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.